BeiGene (ONC)

Profile

Full Name

BeiGene, Ltd.

Ticker Symbol

ONC

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Cayman Islands

IPO

February 2, 2016

Indexes

Not included

Website

http://www.beigene.com

Employees

11000

Key Details

Price

$256.16(+2.82%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$3.81B(+54.96% YoY)

Annual EPS

-$6.11(+27.69% YoY)

PE ratio

-

Next earnings date

May 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$256.16
ONC price is $256.16

30-Day Relative Volume

0.86
ONC 30-day relative volume is 0.86

Price Performance

Price Most recent change

+2.82%
ONC price was up +2.82% on Apr 24, 2025

Price YTD change

+38.68%
ONC price is up +38.68% since January 1st

Price 1-year change

+77.74%
ONC price is up +77.74% year-on-year

Price 3-year change

+56.4%
ONC price is up +56.4% over the past 3 years

Price Range

Price All-time high

$426.56
ONC price is currently -39.95% below its historical high of $426.56

Price 3-year low

$118.18
ONC price is currently +116.75% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$27.55B
ONC market capitalization is $27.55 billion

Market cap 3-year change

+63.8%
ONC market capitalization is up +63.8% over the past 3 years

Market cap All-time high

$37.51B
ONC market capitalization is currently -26.56% below its historical high of $37.51 billion

Market cap sector rank

96.11%
ONC market capitalization is higher than 96.11% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+2.91%
ONC shares outstanding is up +2.91% year-on-year

Shares Outstanding 3-Year Change

+4.73%
ONC shares outstanding is up +4.73% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.49
ONC beta is 0.49

200-day SMA

$209.71
ONC price is currently +22.15% above its 200-day simple moving average

50-day SMA

$248.36
ONC price is currently +3.14% above its 50-day simple moving average

RSI

56.32
ONC 14-day relative strength index is 56.32

Volume

0.86
ONC 30-day relative volume is 0.86

ATR

$11.39
ONC average true range is $11.39

10-day Historical Volatility

80.17%
ONC 10-day historical volatility is 80.17%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$3.81B
ONC annual revenue is $3.81 billion

Revenue Analysts estimate

$5.09B
ONC annual revenue is currently -25.21% lower than the consensus analysts' forecast

Revenue 1-year change

+54.96%
ONC annual revenue is up +54.96% year-on-year

Revenue Sector rank

89.87%
ONC annual revenue is higher than 89.87% of companies in Healthcare sector

EPS

EPS

-$6.11
ONC annual earnings per share is -$6.11

EPS Analysts estimate

$1.09
ONC annual earnings per share is currently -658.55% lower than the consensus analysts' forecast

EPS 1-year change

+27.69%
ONC annual earnings per share is up +27.69% year-on-year

EPS Sector rank

16.28%
ONC annual earnings per share is higher than 16.28% of companies in Healthcare sector

Profit

Gross profit

$3.22B
ONC annual gross profit is $3.22 billion

Gross margin

84.41%
ONC annual gross profit margin is 84.41%

Operating profit

-$568.20M
ONC annual operating income is -$568.20 million

Operating margin

-14.91%
ONC annual operating profit margin is -14.91%

Net income

-$644.79M
ONC annual net profit is -$644.79 million

Net margin

-16.92%
ONC annual net profit margin is -16.92%

Expenses

Total expenses

$4.38B
ONC annual total expenses is $4.38 billion

Operating expenses

$3.78B
ONC annual total operating expenses is $3.78 billion

Cost of goods sold

$594.09M
ONC annual cost of goods sold is $594.09 million

Selling, general & administrative expenses

$1.83B
ONC annual SGA is $1.83 billion

Depreciation and amortization

$171.76M
ONC annual depreciation & amortization is $171.76 million

Interest expense

-
ONC annual interest expense value is unknown

Income tax

$111.78M
ONC annual income tax is $111.78 million

EBIT & EBITDA

EBIT

-$568.20M
ONC annual earnings before interest & taxes is -$568.20 million

EBITDA

-$396.44M
ONC annual EBITDA is -$396.44 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$5.92B
ONC annual total assets is $5.92 billion

Non current assets

$1.93B
ONC annual long term assets is $1.93 billion

Current assets

$3.99B
ONC annual total current assets is $3.99 billion

Cash and cash equivalents

$2.63B
ONC annual cash & cash equivalents is $2.63 billion

Accounts receivable

$676.28M
ONC annual accounts receivable is $676.28 million

Inventory

$494.99M
ONC annual inventory is $494.99 million

Liabilities

Total liabilities

$2.59B
ONC annual total liabilities is $2.59 billion

Long term liabilities

$373.79M
ONC annual total long term liabilities is $373.79 million

Current liabilities

$2.21B
ONC annual total current liabilities is $2.21 billion

Accounts payable

$405.00M
ONC annual accounts payable is $405.00 million

Debt

Total debt

$1.08B
ONC annual total debt is $1.08 billion

Total debt 1-year change

+16.09%
ONC annual total debt is up +16.09% year-on-year

Long term debt

$210.76M
ONC annual long term debt is $210.76 million

Short term debt

$869.11M
ONC annual short term debt is $869.11 million

Equity & Capital

Shareholders equity

$3.33B
ONC annual stockholders equity is $3.33 billion

Book value

$3.33B
ONC annual book value is $3.33 billion

Retained earnings

-$8.61B
ONC annual retained earnings is -$8.61 billion

Working capital

$1.78B
ONC annual working capital is $1.78 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$140.63M
ONC annual cash flow from operations is -$140.63 million

Cash from operations 1-year change

+87.85%
ONC annual cash flow from operations is up +87.85% year-on-year

Cash from investing

-$548.35M
ONC annual cash flow from investing activities is -$548.35 million

Cash from investing 1-year change

-1013.86%
ONC annual cash flow from investing activities is down -1013.86% year-on-year

Cash from financing

$193.45M
ONC annual cash flow from financing activities is $193.45 million

Cash from financing 1-year change

-53.55%
ONC annual cash flow from financing activities is down -53.55% year-on-year

CAPEX

CAPEX

$529.14M
ONC annual capital expenditures is $529.14 million

CAPEX 1-year change

-11.26%
ONC annual capital expenditures is down -11.26% year-on-year

Free Cash Flow

Free cash flow

-$669.77M
ONC annual free cash flow is -$669.77 million

Free cash flow 1-year change

+61.81%
ONC annual free cash flow is up +61.81% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

84.41%
ONC annual gross profit margin is 84.41%

Operating margin

-14.91%
ONC annual operating profit margin is -14.91%

Net margin

-16.92%
ONC annual net profit margin is -16.92%

ROA & ROE

ROA

-11.00%
ONC annual return on assets is -11.00%

ROE

-18.77%
ONC annual return on equity is -18.77%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ONC price to earnings ratio value is unknown

PE ratio Sector rank

-
ONC price to earnings ratio is unknown

PB Ratio

PB ratio

8.27
ONC price to book ratio is 8.27

PB ratio Sector rank

89.71%
ONC price to book ratio is higher than 89.71% of companies in Healthcare sector

PS Ratio

PS ratio

7.23
ONC price to sales ratio is 7.23

PS ratio Sector rank

72.6%
ONC price to sales ratio is higher than 72.6% of companies in Healthcare sector

Enterprise value

Enterprise value

$26.00B
ONC enterprise value is $26.00 billion

Enterprise value Sector rank

96%
ONC enterprise value is higher than 96% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-65.58
ONC EV/EBITDA is -65.58

EV/EBITDA Sector rank

1.85%
ONC EV/EBITDA is higher than 1.85% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.80
ONC annual current ratio is 1.80

Quick ratio

1.58
ONC annual quick ratio is 1.58

Leverage

Debt to equity

0.31
ONC annual debt to equity ratio is 0.31

Interest coverage ratio

-
ONC annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

4
ONC piotroski f-score is 4

Altman Z-Score

5.04
ONC altman z-score is 5.04

Analyst ratings

Recent major analysts updates

Apr 21, 25 JP Morgan
Overweight
Apr 16, 25 Guggenheim
Buy
Apr 10, 25 Guggenheim
Buy
Apr 7, 25 RBC Capital
Outperform
Feb 28, 25 Macquarie
Outperform
Feb 28, 25 Citizens Capital Markets
Market Outperform
Nov 13, 24 TD Cowen
Buy
Oct 22, 24 JP Morgan
Overweight
Sep 18, 24 JMP Securities
Market Outperform
Aug 20, 24 JP Morgan
Overweight

Institutional Ownership

Similar stocks

DXCM logo
DexCom (DXCM)
SMMT logo
Summit Therapeutics (SMMT)
IQV logo
IQVIA Holdings (IQV)
BNTX logo
BioNTech SE (BNTX)
A logo
Agilent Technologies (A)
CNC logo
Centene (CNC)
GEHC logo
GE HealthCare Technologies (GEHC)
ALNY logo
Alnylam Pharmaceuticals (ALNY)
PHG logo
Koninklijke Philips NV (PHG)
  • What is the ticker symbol for BeiGene?
  • Does BeiGene pay dividends?
  • What sector is BeiGene in?
  • What industry is BeiGene in?
  • What country is BeiGene based in?
  • When did BeiGene go public?
  • Is BeiGene in the S&P 500?
  • Is BeiGene in the NASDAQ 100?
  • Is BeiGene in the Dow Jones?
  • When was BeiGene's last earnings report?
  • When does BeiGene report earnings?
  • Should I buy BeiGene stock now?

What is the ticker symbol for BeiGene?

The ticker symbol for BeiGene is NASDAQ:ONC

Does BeiGene pay dividends?

No, BeiGene does not pay dividends

What sector is BeiGene in?

BeiGene is in the Healthcare sector

What industry is BeiGene in?

BeiGene is in the Biotechnology industry

What country is BeiGene based in?

BeiGene is headquartered in Cayman Islands

When did BeiGene go public?

BeiGene's initial public offering (IPO) was on February 2, 2016

Is BeiGene in the S&P 500?

No, BeiGene is not included in the S&P 500 index

Is BeiGene in the NASDAQ 100?

No, BeiGene is not included in the NASDAQ 100 index

Is BeiGene in the Dow Jones?

No, BeiGene is not included in the Dow Jones index

When was BeiGene's last earnings report?

BeiGene's most recent earnings report was on Feb 27, 2025

When does BeiGene report earnings?

The next expected earnings date for BeiGene is May 7, 2025

Should I buy BeiGene stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page